Mat Legut, PhD, combined his scientific expertise with entrepreneurial drive to launch OverT Bio. His team engineers immune cells to seek out and destroy tumors, bringing new treatment options to cancer patients.
While navigating the challenges of building a life sciences startup, Legut found that balancing innovation and business demands required more than vision—he needed the right support. Legut found that with the J.P. Morgan Startup Banking team.
“The biggest challenge in my startup journey was wearing both the scientist hat and the entrepreneur hat. When I met my banker at J.P. Morgan, I saw that we can get exactly the level of care and personal attention that we need, that we’re not just a small fish in a much bigger pond.”
—Mat Legut, Co-founder, OverT Bio
Whether you’re launching a new life sciences venture or scaling for the next milestone, we can help you reach the next level. Connect with J.P. Morgan Startup Banking today, and explore our Innovation Economy content hub for more insights.
JPMorgan Chase Bank, N.A. Member FDIC. Visit jpmorgan.com/commercial-banking/legal-disclaimer for disclosures and disclaimers related to this content.
